Volume 9, Number 11—November 2003
Commentary
Frequency of Revaccination against Smallpox
Table
Residual vaccinia virus neutralizing titers of serum from vaccinated and unvaccinated persons
Participant no. |
Y after vaccination | Neutralizing titer |
---|---|---|
Single-vaccinated persons | ||
A |
47 |
10 |
B |
50 |
26 |
C |
45 |
27 |
D |
40 |
34 |
E |
40 |
43 |
Ordinary commercial immunoglobulin (Panglobulin) |
150 |
|
Unvaccinated persons |
||
H6 |
—a |
<10 |
H9 |
— |
<10 |
C2 |
— |
<10 |
C4 |
— |
<10 |
H1 |
— |
10 |
H2 |
— |
10 |
H13 |
— |
10 |
C1 |
— |
10 |
C3 |
— |
10 |
H7 |
— |
10 |
HL |
— |
20 |
H3 |
— |
20 |
H4 |
— |
20 |
H5 |
— |
20 |
H10 |
— |
20 |
H11 |
— |
20 |
H12 |
— |
20 |
C7 |
— |
20 |
H8 | — | 30 |
a—, Not applicable.